Prostate Cancer Clinical Trials

Showing 601-620 of 2,150 trials

Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)

NCT03807492

The EMPOWeR study is proposed as a cohort study with longitudinal follow-up to determine rates of genetic mutations among men with or at-risk for prostate cancer to address the various facets of genetic education and counseling for optimized genetic assessment and wellness of men. The results will inform practice guidelines and future studies for maximal impact of genetic evaluation of men for inherited prostate cancer.

Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University241 participantsStarted Jan 2019

Philadelphia, Pennsylvania, United States

RECRUITINGPhase 1/2

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

NCT04104776

The purpose of this open-label, first-in-human (FIH) trial is to evaluate the safety, tolerability, and preliminary clinical activity of Tulmimetostat as a monotherapy in patients with advanced solid tumors and lymphomas.

Advanced Solid TumorDiffuse Large B Cell LymphomaLymphoma, T-Cell+5 more

Novartis Pharmaceuticals275 participantsStarted Sep 2019

Atlanta, Georgia, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +57 more locations

Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Related Searches

Salvage Lymph Node Dissection in Prostate Cancer Patients With Recurrence After Radical Prostatectomy

Brodalumab in the Treatment of Immune-Related Adverse Events

Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastatic Prostate Cancer

Hemi-Gland Cryoablation for Prostate Cancer at UCLA

Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy

Multicenter Assessment of Clinical Utility PET / MR With the Use of the Radiotracer 68Ga-PSMA-11 in Therapy Planning Personalized in Patients With Prostate Cancer

A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer

Comparing Water Vapour Thermal Therapy (Rezūm) and TURP

Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment

The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population

Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients

Tempus Priority Study: A Pan-tumor Observational Study

To Identify Potential New Urine Markers for the Screening of Prostate Cancer

Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study)

A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer

Survival Monitoring in Russian Cancer Registries

Focal Salvage Brachytherapy Study (FocaSaBra)

Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer